InvestorsHub Logo
Followers 2
Posts 365
Boards Moderated 0
Alias Born 01/28/2018

Re: None

Thursday, 07/02/2020 4:47:50 PM

Thursday, July 02, 2020 4:47:50 PM

Post# of 5273
Blythe weed project is just one piece of the story. Remember, HEME has a distribution agreement with Advanced Prenatal Therapeutics. APT last year received FDA breakthrough device designation and is the only device on the market to use as a treatment for preeclampsia. APT generates $6mil annual revenue. Wait until this hits the masses $ Going to be huge
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TRFE News